Thalidomide therapy for cicatricial pemphigoid.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 12140460.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Cicatricial pemphigoid is a chronic, presumed autoimmune, blistering disease of the mucous membranes and occasionally of the skin. The characteristic feature is scarring at the sites of healing. We report the use of thalidomide as a therapeutic agent to control previously resistant disease.
Medical subject headings
- Dermatologic Agents
- Immunosuppressive Agents
- Laryngeal Diseases
- Pemphigoid, Benign Mucous Membrane
- Pharyngeal Diseases
- Thalidomide